Basic symptoms and ultrahigh risk criteria: Symptom development in the initial prodromal state

Schizophrenia Bulletin

Volumn 36, Issue 1, 2010, Pages 182-191

  Schultze Lutter, Frauke ^a   Ruhrmann, Stephan ^a   Berning, Julia ^b   Maier, Wolfgang ^b   Klosterkötter, Joachim ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Early course; Early initial prodromal state; Late initial prodromal state; Phenomenology; Psychosis

Indexed keywords

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; EDUCATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSYCHOSIS; RECALL; RECOGNITION; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY ANALYSIS; SYMPTOM;

ADOLESCENT; ADULT; AGE OF ONSET; EARLY DIAGNOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER; SEX FACTORS; YOUNG ADULT;

EID: 73949110927     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbn072     Document Type: Article

References (37)

1. Yung AR, Phillips LJ, McGorry PD, et al. Prediction of psychosis. Br J Psychiatry. 1998;173(suppl 33):14-20.
2. Phillips LJ, Yung AR, McGorry PD. Identification of young people at risk of psychosis: validation of Personal Assessment and Crisis Evaluation Clinic intake criteria. Aust N Z J Psychiatry. 2000;34(suppl):S164-S169.
3. Schultze-Lutter F. Prediction of psychosis is necessary and possible. In: McDonald C, Schultz K, Murray R, Wright P, eds. Schizophrenia: Challenging the Orthodox. London, UK: Taylor & Francis; 2004:81-90.
4. Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001;58:158-164.
5. Ruhrmann S, Schultze-Lutter F, Klosterkötter J. Early detection and intervention in the initial prodromal phase of schizophrenia. Pharmacopsychiatry. 2003;36:suppl 3162-3167
6. Schultze-Lutter F, Ruhrmann S, Klosterkötter J. Can schizophrenia be predicted phenomenologically? In: Johannessen JO, Martindale B, Cullberg J, eds. Evolving Psychosis. Different Stages, Different Treatments. London, UK: Routledge; 2006:104-123.
7. Häfner H, Maurer K, Ruhrmann S, et al. Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci. 2004;254:117-128.
8. Klosterkötter J, Schultze-Lutter F, Ruhrmann S. Früherken- nungssysteme der schizophrenen Erkrankung. In: Falkai P, Pajonk FG, eds. Psychotische Störungen. Systematische Ther-apie mit modernen Neuroleptika. Stuttgart, Germany: Georg Thieme Verlag; 2003:23-35.
9. Yung AR, Yuen HP, Berger G, et al. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull. 2007;33:673-681.
10. Schultze-Lutter F, Ruhrmann S, Hoyer C, Klosterkötter J, Leweke FM. The initial prodrome of schizophrenia: different duration, different underlying deficits? Compr Psychiatry. 2007;48:479-488.
11. McGlashan TH, Hoffman RE. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry. 2000;57:637-648.
12. Köhn D, Pukrop R, Niedersteberg A, et al. Wege in die Behandlung: Hilfesuchverhalten schizophrener Ersterk-rankter. Fortschr Neurol Psychiatr. 2004;72:635-642.
13. Schultze-Lutter F, Picker H, Ruhrmann S, Klosterkötter J. Das Kölner Früh-Erkennungs-& Therapie-Zentrum für psy-chische Krisen (FETZ): Evaluation der Inanspruchnahme. Med Klin. 2008;103:81-89.
14. Mäki P, Veijola J, Jones PB, et al. Predictors of schizophre-nia-a review. Br Med Bull. 2005;73-74:1-15.
15. Cannon TD, Cadenhead K, Cornblatt B, et al. Prediction of psychosis in youth at high clinical risk. Arch Gen Psychiatry. 2008;65:28-37.
16. Norman RM, Malla AK, Manchanda R. Delay in treatment for psychosis: its relation to family history. Soc Psychiatry Psychiatr Epidemiol. 2007;42:507-512.
17. Addington J, Schultze-Lutter F. Prodromal phase of psychosis in adolescent women. In: Romans S, Seeman MV, eds. Women's Mental Health: A Life Cycle Approach. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:123-132.
18. Maurer K, Hörrmann F, Trendler G, Schmidt M, Häfner H. Früherkennung des Psychoserisikos mit dem Early Recognition Inventory (ERIraos). Beschreibung des Verfahrens und erste Ergebnisse zur Reliabilität und Validität der Checkliste. Nervenheilkunde. 2006;1-2:11-16.
19. Miller TJ, McGlashan TH, Lifshey Rosen J, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry. 2002;159:863-865.
20. Yung AR, Yuen HP, McGorry PD, et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry. 2005;39:964-971.
21. Gross G, Huber G, Klosterkötter J, Linz M. Bonner Skala für die Beurteilung von Basissymptomen (BSABS; Bonn Scale for the Assessment of Basic Symptoms). Berlin, Germany: Springer; 1987.
22. Häfner H, Riecher A, Maurer K, et al. Ein Instrument zur retrospektiven Einschätzung des Erkrankungsbeginns bei Schizophrenie (Instrument for the retrospective assessment of the onset of schizophrenia-"IRAOS")-Entwicklung und erste Ergebnisse. Z Klin Psychol. 1990;19:230-255.
23. Häfner H, Maurer K, Trendler G, et al. Schizophrenia and depression: challenging the paradigm of two separate disease-s-a controlled study of schizophrenia, depression and healthy controls. Schizophr Res. 2005;77:11-24.
24. Maurer K, Häfner H. Methodological aspects of the onset assessment in schizophrenia. Schizophr Res. 1995;15:265-276.
25. McGorry PD, Yung AR, Phillips LJ, et al. A randomized controlled trial of interventions designed to reduce the risk of progression to first episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry. 2002;59: 921-928.
26. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res. 2004;67:131-142.
27. Morrison AP, French P, Walford L, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk. Br J Psychiatry. 2004;185:291-297.
28. McGlashan TH, Zipursky RB, Perkins D, et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry. 2006;163:790-799.
29. Häfner H, Nowotny B, Löffler W, an der Heiden W, Maurer K. When and how does schizophrenia produce social deficits? Eur Arch Psychiatr Clin Neurosci. 1995;246:17-28.
30. Mason O, Startup M, Halpin S, Schall U, Conrad A, Carr V. Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'. Schizophr Res. 2004; 71:227-237.
31. Broome RM, Woolley JB, Johns LC, et al. Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state. Eur Psychiatry. 2005;20:372-378.
32. Andrade LH, Viana MC, Tófoli LFF, Wang YP. Influence of psychiatric morbidity and sociodemographic determinants on use of service in a catchment area in the city of São Paulo, Brazil. Soc Psychiatry Psychiatr Epidemiol. 2008;43:45-53.
33. Steele L, Dewa C, Lee K. Socioeconomic status and self-reported barriers to mental health service use. Can J Psychiatry. 2007;52:201-206.
34. Pevalin DJ. Socio-economic inequalities in health and service utilization in the London Borough of Newham. Public Health. 2007;121:596-602.
35. Lampert T. Schichtspezifische Unterschiede im Gesundheitszu-stand und Gesundheitsverhalten. Berlin, Germany: Berliner Zentrum Public Health, Blaue Reihe; 2005.
36. Schultze-Lutter F, Klosterkötter J. Do basic symptoms provide a possible explanation for the elevated risk for schizophrenia among mentally retarded? Neurol Psychiatry Brain Res. 1995;3:29-34.
37. Nelson B, Yung AR, Bechdolf A, McGorry PD. The Phe-nomenological Critique and Self-disturbances: Implications for Ultra-High Risk ("Prodrome") Research. Schizophr Bull. 2008;34:381-392.